CEL-SCI
CEL-SCI Partners with Amarox to Bring Multikine Cancer Therapy to Saudi Arabia
CEL-SCI and Amarox have signed a strategic partnership to develop and distribute Multikine Saudi Arabia cancer immunotherapy under a 50/50 revenue-sharing model, pending SFDA approval.
SSICT News ·